Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 229 | nsp16:I229V; | CL-2; |
| 237 | nsp16:I237-; | CL-3f; |
| 237 | nsp16:I237L; | CL-3d; |
| 237 | nsp16:I237N; | CL-2; |
| 237 | nsp16:I237T; | CL-1a;CL-2; |
| 267 | nsp16:I267-; | CL-3b;CL-3e; |
| 267 | nsp16:I267F; | CL-3e; |
| 271 | nsp16:I271-; | CL-3b; |
| 281 | nsp16:I281T; | CL-3b; |
| 282 | nsp16:I282V; | CL-3d; |
| 290 | nsp16:I290-; | CL-3e;CL-3f; |
| 290 | nsp16:I290T; | CL-3d; |
| 40 | nsp16:I40-; | CL-3a;CL-3e; |
| 40 | nsp16:I40M; | CL-3d; |
| 40 | nsp16:I40V; | CL-3e; |
| 123 | nsp16:K123R; | CL-3e; |
| 137 | nsp16:K137-; | CL-3e; |
| 141 | nsp16:K141-; | CL-3b;CL-3f; |
| 141 | nsp16:K141T; | CL-3d;CL-3e; |
| 160 | nsp16:K160E; | CL-3b; |
| 182 | nsp16:K182-; | CL-3b;CL-3d;CL-3e; |
| 182 | nsp16:K182R; | CL-3e; |
| 24 | nsp16:K24-; | CL-3b; |
| 249 | nsp16:K249N; | CL-3b;CL-3d;CL-3e;CL-3f; |
| 249 | nsp16:K249R; | CL-2;CL-3d; |
| 263 | nsp16:K263N; | CL-3e; |
| 263 | nsp16:K263R; | CL-3b;CL-3e; |
| 277 | nsp16:K277-; | CL-3b; |
| 277 | nsp16:K277E; | CL-2;CL-3d; |
| 277 | nsp16:K277N; | CL-2;CL-3e; |
| 277 | nsp16:K277S; | CL-3e; |
| 38 | nsp16:K38G; | CL-3a; |
| 38 | nsp16:K38R; | CL-3b; |
| 76 | nsp16:K76-; | CL-3e; |
| 100 | nsp16:L100I; | CL-3d;CL-3e; |
| 100 | nsp16:L100Q; | CL-3b; |
| 111 | nsp16:L111-; | CL-5; |
| 111 | nsp16:L111F; | CL-1b;CL-3b;CL-3c;CL-3d;CL-3e;CL-3f; |
| 111 | nsp16:L111M; | CL-3e; |
| 126 | nsp16:L126V; | CL-2;CL-3e; |
| 14 | nsp16:L14F; | CL-2;CL-3c;CL-3d; |
| 14 | nsp16:L14I; | CL-3e; |
| 161 | nsp16:L161-; | CL-3b; |
| 163 | nsp16:L163-; | CL-1a_3d;CL-3b;CL-3d;CL-3e; |
| 163 | nsp16:L163I; | CL-3b;CL-3c;CL-3d;CL-3e; |
| 163 | nsp16:L163P; | CL-3d;CL-5; |
| 163 | nsp16:L163R; | CL-3c;CL-3f;CL-4; |
| 180 | nsp16:L180I; | CL-3d; |
| 183 | nsp16:L183-; | CL-3b; |
| 183 | nsp16:L183A; | CL-3b;CL-3e; |
Page 216 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com